Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Keravision(kera) -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Vayda who wrote (213)	8/13/1999 7:59:00 AM
From: oilbabe	Respond to of 338

Thanks, Jeff. Those are my thoughts exactly, however it is good to have them confirmed by someone who obviously knows more about this company than I do...

To: Jeff Vayda who wrote (213)	8/13/1999 1:02:00 PM
From: W Van	Read Replies (1) \| Respond to of 338

Hi Jeff, Nice synopsis on Kera. I have been long Kera for quite a while and it can be volatile for sure but the technology is wonderful. As you say, if management can execute this will be winner. I think Kera will leave its "natural home" when we see verified growing acceptance of the procedure based on the number of procedures done. I've seen a lot of unsupported claims of increasing procedures on the Yahoo board. Although the claims are unsupported some of the posters seem pretty legit. I know, that most of the time, the choice between Intacs and Laser will be Intacs if it is an INFORMED patient making the choice. The upgrade from Prudential was great news and I would guess there will be more to follow. Oh yeah, as far as management goes I think they are doing a first rate job. Just my 2 cents.